Pancreatitis or inflammation of the pancreas comes in both acute and chronic forms and has long been appreciated as a risk factor for developing pancreatic cancer. While common and in […]
Innovative Glycoengineering Strategy Could Reveal New Biomarkers for Pancreatic Cancer
While the 5-year survival rate for pancreatic cancer has increased over the last decade to 13%, it continues to be one of the toughest cancers to diagnose and treat. One […]
Progress Towards a Less Invasive Treatment for Pancreatic Neuroendocrine Tumors
Pancreatic neuroendocrine tumors, also called PNETs or PanNETs, are the second most common type of pancreatic cancer after pancreatic ductal adenocarcinomas or PDACs. While PDACs arise from ductal or exocrine […]
Our 2025 UCLA Catalyst Grant Winners are Driving Research Towards Better Treatment Options
As we celebrate the 20th anniversary of our pioneering Seed Grant Program, we are proud to announce the launch of a new era in our mission to drive scientific breakthroughs: […]
Dr. Anna Gukovskaya: From Seed Grant to Global Recognition in Pancreatic Research
Our Seed Grant Program has fostered an environment where research can bloom. As we mark 20 years since our first cohort of grantees, it is inspiring to reflect on the […]
Dr. Evan Abt: Advancing Immuno-Metabolic Therapies for Pancreatic Cancer
As we celebrate the 20th anniversary of our Seed Grant Program, we’re proud to highlight a new generation of researchers leading the charge to cure pancreatic cancer. Among them is […]